Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of key genes as novel biomarkers specifically associated with HPV-negative cervical cancer. | Mol Ther Methods Clin Dev | 2021 | 33997099 | PubTator, text mining | PubMed |
| Cysteine Cathepsins and Matrix Metalloproteases Among Breast Cancer Patients. | Breast Cancer (Dove Med Press) | 2021 | 33994807 | PubTator, text mining | PubMed |
| Intraductal carcinoma of the salivary gland with NCOA4-RET: expanding the morphologic spectrum and an algorithmic diagnostic approach. | Hum Pathol | 2021 | 33991527 | PubTator, text mining | PubMed |
| SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress. | J Exp Clin Cancer Res | 2021 | 33990217 | PubTator, text mining | PubMed |
| ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control. | J Clin Invest | 2021 | 33983905 | PubTator, text mining | PubMed |
| MRI detection of the malignant transformation of stem cells through reporter gene expression driven by a tumor-specific promoter. | Stem Cell Res Ther | 2021 | 33980305 | PubTator, text mining | PubMed |
| Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma. | Front Endocrinol (Lausanne) | 2021 | 33967965 | PubTator, text mining | PubMed |
| Glucose-Regulated Protein 94 Mediates the Proliferation and Metastasis through the Regulation of ETV1 and MAPK Pathway in Colorectal Cancer. | Int J Med Sci | 2021 | 33967600 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Naive stem cell blastocyst model captures human embryo lineage segregation. | Cell Stem Cell | 2021 | 33957081 | PubTator, text mining | PubMed |
| Prognostic and immunological potential of PPM1G in hepatocellular carcinoma. | Aging (Albany NY) | 2021 | 33952716 | PubTator, text mining | PubMed |
| SRC-3, a Steroid Receptor Coactivator: Implication in Cancer. | Int J Mol Sci | 2021 | 33946224 | PubTator, text mining | PubMed |
| The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression. | Cell Death Dis | 2021 | 33931578 | PubTator, text mining | PubMed |
| The chromatin accessibility landscape reveals distinct transcriptional regulation in the induction of human primordial germ cell-like cells from pluripotent stem cells. | Stem Cell Reports | 2021 | 33930315 | PubTator, text mining | PubMed |
| Transmembrane and Tetratricopeptide Repeat Containing 4 Is a Novel Diagnostic Marker for Prostate Cancer with High Specificity and Sensitivity. | Cells | 2021 | 33925440 | PubTator, text mining | PubMed |
| Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis. | Cancers (Basel) | 2021 | 33924679 | PubTator, text mining | PubMed |
| The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications. | Int J Mol Sci | 2021 | 33923400 | PubTator, text mining | PubMed |
| The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development. | Int J Mol Sci | 2021 | 33923108 | PubTator, text mining | PubMed |
| Diagnostic Immunohistochemistry of Soft Tissue and Bone Tumors: An Update on Biomarkers That Correlate with Molecular Alterations. | Diagnostics (Basel) | 2021 | 33921435 | PubTator, text mining | PubMed |
| Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives. | J Clin Med | 2021 | 33919988 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=43